XML 32 R21.htm IDEA: XBRL DOCUMENT v3.6.0.2
Intangible Assets
 3 Months Ended
Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets
Intangible Assets
Intangible assets consisted of the following:
 
Description
As of December 31, 2016
 
As of September 24, 2016
Gross
Carrying
Value
 
Accumulated
Amortization
 
Gross
Carrying
Value
 
Accumulated
Amortization
Developed technology
$
3,727.4

 
$
1,962.9

 
$
3,983.7

 
$
1,991.6

In-process research and development
3.7

 
—

 
3.7

 
—

Customer relationships and contracts
512.1

 
366.9

 
1,098.9

 
546.2

Trade names
236.1

 
144.1

 
236.2

 
141.6

Business licenses
2.3

 
2.0

 
2.4

 
2.1

 
$
4,481.6


$
2,475.9


$
5,324.9


$
2,681.5


In the first quarter of fiscal 2017, the Company classified the assets of its blood screening business as assets held for sale. As such, developed technology and customer contract assets of $154.0 million and $387.7 million, respectively, were reclassified accordingly in the Company's Consolidated Balance Sheet as of December 31, 2016.
The estimated remaining amortization expense as of December 31, 2016 for each of the five succeeding fiscal years is as follows:
Remainder of Fiscal 2017
$
210.1

Fiscal 2018
$
286.5

Fiscal 2019
$
274.8

Fiscal 2020
$
264.2

Fiscal 2021
$
242.6